Skip to content

Inspection Device For Cervical Cancer Screening

GynaeCam - Inspection Device For Cervical Cancer Screening - A pilot study at Chennai.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/07/009005
Enrollment
600
Registered
2017-07-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Gyneacam: Screening device for early detection of pre-cancerous lesion. The trial period 1 year.

Sponsors

IIT Bombay
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women with an intact uterus, ever married, Women patients who visit the hospital for PAP Smear will also be enrolled, with prior consent.

Exclusion criteria

Exclusion criteria: Women who are pregnant /undergone hysterectomy/ treated for pre-cancers or cancers in the past / menstruating will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Concordance between Gyneacam and Pap smear results.Timepoint: 1 Year

Secondary

MeasureTime frame
Quality of imagesTimepoint: 1 year

Countries

India

Contacts

Public ContactMsSripriya

IIT Bombay

noronha@iitb.ac.in02225767238

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026